Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs

Hideya Iijima, Gen Tamura, Tzuen-Ren Hsiue, Yi Liu, Hajime Taniguchi, Kunio Shirato

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

The effect of suplatast tosilate, which has been proven to inhibit T- cell synthesis of IL-4 and IL-5, on the response to antigen inhalation challenge was investigated in sensitized guinea pigs. The animals were given an oral dose of 30 or 100 mg/kg of suplatast or vehicle (distilled water) daily for 1 wk before antigen challenge. Measurement of pulmonary resistance for 6 h was followed by bronchoalveolar lavage and lung fixation. After antigen challenge, all guinea pigs in the vehicle group displayed dual-phase airway obstruction and accumulation of eosinophils and lymphocytes in the airways. After 1 wk of treatment with the high dose of suplatast, the late asthmatic response and the recruitment of eosinophils and lymphocytes into the airways were significantly inhibited, but the early asthmatic response was not affected. In situ hybridization revealed that challenge-induced increases in IL-5 mRNA-positive cells in lung tissue were significantly inhibited after treatment. Thus, suplatast inhibited airway obstruction in the late phase by specifically inhibiting the inflammatory process after mast cell degranulation.

Original languageEnglish
Pages (from-to)331-335
Number of pages5
JournalAmerican Journal of Respiratory and Critical Care Medicine
Volume160
Issue number1
DOIs
Publication statusPublished - 1999 Jan 1

Fingerprint

Guinea Pigs
Interleukin-5
Airway Obstruction
Inflammation
Antigens
Eosinophils
Lung
Lymphocytes
Cell Degranulation
Bronchoalveolar Lavage
Mast Cells
Interleukin-4
Inhalation
In Situ Hybridization
T-Lymphocytes
Messenger RNA
Water
Therapeutics
suplatast tosilate

All Science Journal Classification (ASJC) codes

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine

Cite this

Iijima, Hideya ; Tamura, Gen ; Hsiue, Tzuen-Ren ; Liu, Yi ; Taniguchi, Hajime ; Shirato, Kunio. / Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. In: American Journal of Respiratory and Critical Care Medicine. 1999 ; Vol. 160, No. 1. pp. 331-335.
@article{e24766fe85324564b1f737ad0a50dbc0,
title = "Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs",
abstract = "The effect of suplatast tosilate, which has been proven to inhibit T- cell synthesis of IL-4 and IL-5, on the response to antigen inhalation challenge was investigated in sensitized guinea pigs. The animals were given an oral dose of 30 or 100 mg/kg of suplatast or vehicle (distilled water) daily for 1 wk before antigen challenge. Measurement of pulmonary resistance for 6 h was followed by bronchoalveolar lavage and lung fixation. After antigen challenge, all guinea pigs in the vehicle group displayed dual-phase airway obstruction and accumulation of eosinophils and lymphocytes in the airways. After 1 wk of treatment with the high dose of suplatast, the late asthmatic response and the recruitment of eosinophils and lymphocytes into the airways were significantly inhibited, but the early asthmatic response was not affected. In situ hybridization revealed that challenge-induced increases in IL-5 mRNA-positive cells in lung tissue were significantly inhibited after treatment. Thus, suplatast inhibited airway obstruction in the late phase by specifically inhibiting the inflammatory process after mast cell degranulation.",
author = "Hideya Iijima and Gen Tamura and Tzuen-Ren Hsiue and Yi Liu and Hajime Taniguchi and Kunio Shirato",
year = "1999",
month = "1",
day = "1",
doi = "10.1164/ajrccm.160.1.9809059",
language = "English",
volume = "160",
pages = "331--335",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "1",

}

Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs. / Iijima, Hideya; Tamura, Gen; Hsiue, Tzuen-Ren; Liu, Yi; Taniguchi, Hajime; Shirato, Kunio.

In: American Journal of Respiratory and Critical Care Medicine, Vol. 160, No. 1, 01.01.1999, p. 331-335.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Suplatast tosilate inhibits late response and airway inflammation in sensitized guinea pigs

AU - Iijima, Hideya

AU - Tamura, Gen

AU - Hsiue, Tzuen-Ren

AU - Liu, Yi

AU - Taniguchi, Hajime

AU - Shirato, Kunio

PY - 1999/1/1

Y1 - 1999/1/1

N2 - The effect of suplatast tosilate, which has been proven to inhibit T- cell synthesis of IL-4 and IL-5, on the response to antigen inhalation challenge was investigated in sensitized guinea pigs. The animals were given an oral dose of 30 or 100 mg/kg of suplatast or vehicle (distilled water) daily for 1 wk before antigen challenge. Measurement of pulmonary resistance for 6 h was followed by bronchoalveolar lavage and lung fixation. After antigen challenge, all guinea pigs in the vehicle group displayed dual-phase airway obstruction and accumulation of eosinophils and lymphocytes in the airways. After 1 wk of treatment with the high dose of suplatast, the late asthmatic response and the recruitment of eosinophils and lymphocytes into the airways were significantly inhibited, but the early asthmatic response was not affected. In situ hybridization revealed that challenge-induced increases in IL-5 mRNA-positive cells in lung tissue were significantly inhibited after treatment. Thus, suplatast inhibited airway obstruction in the late phase by specifically inhibiting the inflammatory process after mast cell degranulation.

AB - The effect of suplatast tosilate, which has been proven to inhibit T- cell synthesis of IL-4 and IL-5, on the response to antigen inhalation challenge was investigated in sensitized guinea pigs. The animals were given an oral dose of 30 or 100 mg/kg of suplatast or vehicle (distilled water) daily for 1 wk before antigen challenge. Measurement of pulmonary resistance for 6 h was followed by bronchoalveolar lavage and lung fixation. After antigen challenge, all guinea pigs in the vehicle group displayed dual-phase airway obstruction and accumulation of eosinophils and lymphocytes in the airways. After 1 wk of treatment with the high dose of suplatast, the late asthmatic response and the recruitment of eosinophils and lymphocytes into the airways were significantly inhibited, but the early asthmatic response was not affected. In situ hybridization revealed that challenge-induced increases in IL-5 mRNA-positive cells in lung tissue were significantly inhibited after treatment. Thus, suplatast inhibited airway obstruction in the late phase by specifically inhibiting the inflammatory process after mast cell degranulation.

UR - http://www.scopus.com/inward/record.url?scp=0032803848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032803848&partnerID=8YFLogxK

U2 - 10.1164/ajrccm.160.1.9809059

DO - 10.1164/ajrccm.160.1.9809059

M3 - Article

VL - 160

SP - 331

EP - 335

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 1

ER -